Literature DB >> 35314844

CAR T cells reach clinical milestone in prostate cancer.

Nicholas P Tschernia1, Scott M Norberg1, James L Gulley2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35314844     DOI： 10.1038/s41591-022-01742-1

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  8 in total

1.  Postmarketing Analysis of Sipuleucel-T-The Importance of Real-World Data.

Authors:  Alice C Fan; John T Leppert
Journal:  JAMA Netw Open       Date:  2019-08-02

2.  CAR-T efficacy: is conditioning the key?

Authors:  Sattva S Neelapu
Journal:  Blood       Date:  2019-04-25       Impact factor: 22.113

3.  Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses.

Authors:  Vanessa A Fabrizio; M Irene Rodriguez-Sanchez; Audrey Mauguen; Parastoo B Dahi; Ekaterina Doubrovina; Richard J O'Reilly; Susan E Prockop
Journal:  Blood Adv       Date:  2021-01-26

Review 4.  Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer.

Authors:  Tanya B Dorff; Vivek Narayan; Stephen J Forman; Peter D Zang; Joseph A Fraietta; Carl H June; Naomi B Haas; Saul J Priceman
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 13.801

5.  PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.

Authors:  In-Young Jung; Simon F Lacey; Andrew J Rech; Megan M Davis; Carl H June; Joseph A Fraietta; Naomi B Haas; Vivek Narayan; Julie S Barber-Rotenberg; Wei-Ting Hwang; Priti Lal; Erica L Carpenter; Shannon L Maude; Gabriela Plesa; Neha Vapiwala; Anne Chew; Michael Moniak; Ronnie A Sebro; Michael D Farwell; Amy Marshall; Joan Gilmore; Lester Lledo; Karen Dengel; Sarah E Church; Tyler D Hether; Jun Xu; Mercy Gohil; Thomas H Buckingham; Stephanie S Yee; Vanessa E Gonzalez; Irina Kulikovskaya; Fang Chen; Lifeng Tian; Kyle Tien; Whitney Gladney; Christopher L Nobles; Hayley E Raymond; Elizabeth O Hexner; Donald L Siegel; Frederic D Bushman
Journal:  Nat Med       Date:  2022-03-21       Impact factor: 87.241

Review 6.  Engineering strategies to overcome the current roadblocks in CAR T cell therapy.

Authors:  Sarwish Rafiq; Christopher S Hackett; Renier J Brentjens
Journal:  Nat Rev Clin Oncol       Date:  2019-12-17       Impact factor: 65.011

7.  Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients.

Authors:  Luca Biasco; Natalia Izotova; Christine Rivat; Sara Ghorashian; Rachel Richardson; Aleks Guvenel; Rachael Hough; Robert Wynn; Bilyana Popova; Andre Lopes; Martin Pule; Adrian J Thrasher; Persis J Amrolia
Journal:  Nat Cancer       Date:  2021-05-24

Review 8.  How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.

Authors:  Jacob Stultz; Lawrence Fong
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-04-05       Impact factor: 5.554
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.